arrow
G

Gerty Schreibelt

radboud university nijmegen
H指数:46
被引数:7,271

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

NEOadjuvant Dendritic cell therapy added to first line standard of care in advanced epithelial Ovarian Cancer (NEODOC): protocol of a first-in-human, exploratory, single-centre phase I/II trial in the Netherlands

新辅助树突状细胞疗法联合一线标准治疗方案在晚期上皮性卵巢癌中的应用(NEODOC):一项在荷兰开展的首次人体、探索性、单中心I/II期临床试验方案

2025-11-093
OA
Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with constitutional mismatch repair deficiency

解析影响常染色体错配修复缺陷个体肿瘤突变模式的致突变过程

2025-05-141
OA
Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial

基于随机佐剂树突状细胞的mind-dc试验中微生物相关代谢重编程对黑色素瘤患者临床结局的影响

2024-02-236
OAAI
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial
2024-02-233
OAAI
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
2022-07-0482
OA
What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings

细胞疗法的制造成本是多少?促进学术和其他小规模细胞疗法制造成本的框架和方法

2020-07-0145
OAAI
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
2019-11-1484
OAAI